Colm Magee, MD, MPH, FRCPI Renal Unit, Beaumont Hospital Nov 2015 Quality and Safety in Therapeutic Plasma Exchange (TPE)

Slides:



Advertisements
Similar presentations
The lymphatic system and immunity
Advertisements

Plasma Exchange consists of the removal of large volumes of the patient' s plasma and replacing it with exogenous plasma or plasma substitutes Action:
Heather D. Mannuel, MD, MBA March 12, 2008
Electrolyte and Metabolic Disturbances AHMED GHALI MD.
Principals of fluids and electrolytes management
Kidney Dialysis and Transplants
Protein-, Mineral- & Fluid-Modified Diets for Kidney Diseases
End Stage Renal Disease in Children. End stage kidney disease occurs when the kidneys are no longer able to function at a level that is necessary for.
IN THE NAME OF GOD.
Continuous Renal Replacement Therapy. Why continuous Therapies? Continuous therapies closely mimic the GFR of native kidneys Large amounts of fluid.
BLEEDING DISORDERS AN OVERVIEW WITH EMPHASIS ON EMERGENCIES.
Blood Components Dosage And Their Administration
BLOOD BANKING 1- BLOOD PRODUCTS 2- AUTOLOGOUS TRANSFUSION M. H. Shaheen Maadi Armed Forces Hospital.
Therapeutic Plasma Exchange for Myasthenia Gravis Clifford Blieden, MD Houston Methodist Hospital Department of Pathology and Genomic Medicine, Division.
PRINCIPLES OF DIALYSIS DR SAAD ALSHOHAIB ASSOCIATE PROFESSOR IN MEDICINE AND NEPHROLOGY KAUH.
Liver failure.
BLOOD TRANSFUSION Begashaw M (MD).
Heart Failure, HF CHF develops when plasma volume increases and fluid accumulates in the lungs, abdominal organs (liver especially), and peripheral tissues.
Specific weight Size Plasma1, μm Platelets1, μm Lymphocytes1, μm Monocytes1, μm Eosinophils1,
Apheresis Matthew L. Paden, MD
CHRONIC RENAL FAILURE R.Manoj Kumar.
1990 Heart transplant 1990 Terminally-ill journalist Adrian Sudbury is campaigning to educate young adults about what it means to be a bone marrow donor.
Plasmapheresis: Basic Principles
THERAPEUTIC PLASMA EXCHANGE OUR EXPERIENCE AT SALEM
Thrombotic Thrombocytopenic Purpura(TTP) Post -AllogeneicTransplant A haematological emergency: a nursing.
BLOOD TRANSFUSION NUR 317. TRANSFUSION Infusion of blood products for the purpose of restoring circulating volume.
Blood Component Therapy
Practical Considerations for CRRT Helen Currier RN, BSN, CNN Nancy McAfee RN, BSN, CNN.
Anticoagulation in CRRT
Experiences with plasmapheresis in our pediatric dialysis unit L. Koster-Kamphuis, E. Cornelissen, E. Levtchenko, N. van de Kar Dept. of Pediatric Nephrology.
Jeff Kaufhold MD FACP April 2009
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
Current Trends in Transplantation Karin True MD, FASN Assistant Professor UNC Kidney Center May 23, 2011.
MEERA LADWA ACUTE KIDNEY INJURY. WHAT IS ACUTE KIDNEY INJURY? A rapid fall in glomerular filtration rate (GFR) In practice, since measuring GFR is difficult,
Goodpasture’s Syndrome and Anti- GBM disease. Goodpasture’s Syndrome Introduction Concurrence of pulmonary hemorrhage and focal necrotizing glomerulonephritis.
The complications can be broadly classified into two categories: Immune Complications Non-immune Complications.
Blood Groups and Blood Transfusion Dr Stuart Laidlaw Haematology Royal Hallamshire Hospital.
U # Chronic renal failure – secondary to IgA nephropathy. Deceased donor kidney transplant – August Complicated by delayed graft.
DOSAGE ADJUSTMENT IN RENAL AND HEPATIC DISEASES Course Title : Biopharmaceutics and Pharmacokinetics – II Course Teacher : Zara Sheikh.
Health issues linked to the kidney. Sometimes the kidney stops working properly, and may even stop working altogether If this happens, excess water and.
Blood and Blood Products. Whole Blood n Contents –RBC’s –WBC’s –Platelets –Plasma –Clotting factors.
Timothy W. Felton, Caroline Baxter, Caroline B. Moore, Stephen A.Roberts, William W. Hope,and David W. Denning Clinical Infectious Diseases 2010; 51:1383–1391.
Plasma and plasma components in the management of disseminated intravascular coagulation Marcel Levi* Academic Medical Center, University of Amsterdam,
Presentation by JoAnn Czech RN/CDS St. Cloud Hospital.
Yadegarynia, D. MD..
Prothrombin complex concentrate
Nephrology Specialist at New Mansoura General Hospital
Plasmapheresis Treatment for Myasthenia Gravis
TRANSFUSION REACTIONS
Transfusion Medicine: Types, Indications and Complications
د.محمد حارث الساعاتي.
Plasma Exchange Chan King Chung.
CASE PRESENTATION DR SANJAY MAITRA, DR DENISH SAVALIA,
KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients 순천향대학교 서울병원 신장내과 R2 김윤석.
BLOOD TRANSFUSION An overview
Therapeutic plasma exchange in children with acute autoimmune central nervous system disorders Agnieszka Prytuła (1), Johan Vande Walle.
Renal Disease Filtration, glomeruli generate removal ultrafiltrate of the plasma based on size and charge of molecules End products include urea, creatinine,
Acute renal failure from hemolytic transfusion reactions
The lymphatic system and immunity
Volume 75, Pages S55-S58 (February 2009)
The Lymphatic System Pages
Renal replacement therapy
Therapeutic Plasma Exchange
SCUF Slow Continuous Ultrafiltration
AKI – Acute Kidney Injury
Plasmapheresis With (and Without) CRRT
Acute / Chronic Glomerulonephritis
DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM
Blood Components Dosage And Their Administration
Presentation transcript:

Colm Magee, MD, MPH, FRCPI Renal Unit, Beaumont Hospital Nov 2015 Quality and Safety in Therapeutic Plasma Exchange (TPE)

Background Removal of plasma and replacement with certain components of plasma Goal is usually removal of a toxic plasma protein In practice, all plasma proteins are removed Either use a filter or a centrifuge system

How does it work? Removal of toxic molecule e.g. anti- GBM, ULVWf multimers Possibly, removal of other inflammatory mediators e.g. complement Restoration of deficient factors e.g. ADAMTS13 in HUS / TTP

Blood / Plasma Constituents BloodPlasma IgM, IgG, other Igs Clotting factors Water + Electrolytes Other proteins Toxic molecule

Standard Plasmapheresis

Double Filtration Plasmapheresis

DFPP AdvantagesDisadvantages More selective r/o plasma products System more complex? Minimal albumin replacement needed Cost of extra filter Minimal FFP replacement needed Extra staff training? Cost?

Indications: Renal (non-transplant) Anti-GBM disease ANCA vasculitis (severe: with Cr >500 or pulmonary haemorrhage) Certain forms of HUS / TTP

Indications: Renal Transplant Desensitization across HLA incompatability for kidney transplant Desensitization across ABO incompatability for kidney transplant Acute antibody mediated rejection of transplant Recurrence of primary FSGS

Anti-A Titer Days Neg Transplant 1/128 TPE Rituximab Typical Protocol for Desensitization

What about Myeloma? Acute renal failure a/w myeloma: the evidence is now poor Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial; Clark et al. 2005, 143: Hyperviscosity syndrome a/w myeloma is still an indication for TPE

Indications: NonRenal Myesthenia gravis Acute and chronic demyelinating neuropathies Anti-NMDA receptor encephalitis TTP (emergency) Hyperviscosity syndrome Catastrophic anti-phospholipid syndrome

Prescription Will depend on urgency of removal of toxic macromolecule and the type of molecule and the disease IgM mainly intravascular – easily removed IgG only 50% intravascular – less easily removed Rebound!

Prescription Daily in severe anti-GBM disease or TTP 1.0 plasma volume = 60% removal 1.5 plasma volume = 75% removal Or: ml / kg Approx 5 sessions over 8 days removes 90% of IgG (assuming minimal new synthesis) Often we do 5-7 sessions over 10 days then pause and reassess

Calculating Volumes Estimated plasma volume (in litres) = 0.07 x wt (kg) x (1 - hematocrit) So, 1 plasma volume in 80kg male with Hct of 30 (0.3) = 0.07 x 80 x 0.7 = 3.92L 1.5 plasma volumes = 3.92 x 1.5 = 5.88L Whereas… 1 plasma volume in 60kg female with Hct of 35 (0.35) = 0.07 x 60 x 0.65 = 2.73L

Replacement Fluids Depend on underlying disease Some combination of: albumin + NS + FFP Where FFP not indicated: 2/3 albumin + 1/3 NS Where FFP is indicated: % replaced as FFP varies Hyperviscosity: 100% replace with NS!

Other Practical Points Always prescribe some heparin, as otherwise, system will clot Immunosuppressive drugs usually prescribed also Ensure any antibody therapies or other critical therapies are NOT given just before TPE In renal transplant, IVIg often given after the course of TPE

Indications for Replacement with FFP HUS / TTP (replace 100% with FFP) Kidney biopsy / surgery / other invasive procedure within last 48 hrs (partially replace with FFP) Active / recent bleeding inc pulmonary hemorrhage Multiple TPE sessions even if no bleeding: partially replace with FFP every 3rd-4 th session

Complications Related to vascular access Hypotension Allergic reactions Hypocalcemia – especially if using FFP (citrate) Metabolic alkalosis if lots of FFP (citrate) Coagulapathy / bleeding Infection

When do you stop? Severe complications Markers of disease have normalised e.g. LDH, plts in HUS / TTP Levels of toxic molecule now normal e.g. anti-GBM but watch for rebound! Sometimes empiric Again, depends whether IgG or IgM

ComplicationPrevention / Treatment HypotensionSlow removal of plasma; bolus with NS Allergic reactionsAvoid ACE-I; minimise FFP; premedicate with paracetemol, anti-histamines HypocalcemiaMinimise FFP; slow infusion of FFP; IV or PO calcium AlkalosisMinimise FFP ThrombocytopeniaAdequate heparin! Coagulapathy / Bleeding Adequate FFP; only do within 24hrs of bx / procedure if TPE urgently indicated Minimising Complications

What Prescription? 1.70kg male with severe TTP 2.60kg female with hyperviscosity syndrome (IgM paraprotein) 3.80kg male with acute anti-GBM disease (renal limited) 4.60kg lady with acute pulmonary-renal syndrome, ANCA+